From our latest issue...
- Improving the translation of disease biology though phenomics
- Cancer drug screening: the historical perspective
- From fibroblasts to medicinal signalling cells: a paradigm shift in translational stem cell research
- Urine-derived stem cells as innovative platform for drug testing and disease modelling
- Genomics in drug development and safety testing; from target identification to genomic toxicology